Factbox: What’s next for OxyContin maker Purdue Pharma

FILE PHOTO: A pharmacist holds a bottle OxyContin made by Purdue Pharma at a pharmacy in Provo, Utah, U.S., May 9, 2019. REUTERS/George Frey/File Photo

(Reuters) – OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis. Supporters of Purdue’s plan to restructure under terms of a settlement the company values at more than $10 billion include 24 states and five U.S. […]

Continue reading this article with a Fiji Times online membership.

More Stories